메뉴 건너뛰기




Volumn 34, Issue 24, 2013, Pages

Effect of statin therapy on cardiovascular and renal outcomes in patients with chronic kidney disease: A systematic review and meta-analysis

Author keywords

Cardiovascular events; Chronic kidney disease; Meta analysis; Statin

Indexed keywords

ATORVASTATIN; CREATININE; EZETIMIBE; FLUINDOSTATIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MEVINOLIN; PLACEBO; PRAVASTATIN; ROSUVASTATIN; SIMVASTATIN;

EID: 84879544916     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/eht065     Document Type: Article
Times cited : (160)

References (45)
  • 1
    • 77950513204 scopus 로고    scopus 로고
    • Early recognition and prevention of chronic kidney disease
    • James MT, Hemmelgarn BR, Tonelli M. Early recognition and prevention of chronic kidney disease. Lancet 2010;375:1296-1309.
    • (2010) Lancet , vol.375 , pp. 1296-1309
    • James, M.T.1    Hemmelgarn, B.R.2    Tonelli, M.3
  • 2
    • 4644221457 scopus 로고    scopus 로고
    • Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization
    • Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 2004; 351:1296-1305.
    • (2004) N Engl J Med , vol.351 , pp. 1296-1305
    • Go, A.S.1    Chertow, G.M.2    Fan, D.3    McCulloch, C.E.4    Hsu, C.Y.5
  • 4
    • 0034079643 scopus 로고    scopus 로고
    • Cardiovascular disease and chronic renal disease: A new paradigm
    • Sarnak MJ, Levey AS. Cardiovascular disease and chronic renal disease: a new paradigm. Am J Kidney Dis 2000;35(4 Suppl. 1):S117-S131.
    • (2000) Am J Kidney Dis , vol.35 , Issue.4 SUPPL. 1
    • Sarnak, M.J.1    Levey, A.S.2
  • 5
    • 59449108700 scopus 로고    scopus 로고
    • KDOQI hypertension, dyslipidemia, and diabetes care guidelines and current care patterns in the United States CKD population: National Health and Nutrition Examination Survey 1999-2004
    • Snyder JJ, Collins AJ. KDOQI hypertension, dyslipidemia, and diabetes care guidelines and current care patterns in the United States CKD population: National Health and Nutrition Examination Survey 1999-2004. Am J Nephrol 2009;30: 44-54.
    • (2009) Am J Nephrol , vol.30 , pp. 44-54
    • Snyder, J.J.1    Collins, A.J.2
  • 7
    • 0031733696 scopus 로고    scopus 로고
    • Clinical epidemiology of cardiovascular disease in chronic renal disease
    • Foley RN, Parfrey PS, Sarnak MJ. Clinical epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis 1998;32(5 Suppl. 3):S112-S119.
    • (1998) Am J Kidney Dis , vol.32 , Issue.5 SUPPL. 3
    • Foley, R.N.1    Parfrey, P.S.2    Sarnak, M.J.3
  • 11
    • 84865628946 scopus 로고    scopus 로고
    • Benefits and harms of statin therapy for persons with chronic kidney disease: A systematic review and meta-analysis
    • Palmer SC, Craig JC, Navaneethan SD, Tonelli M, Pellegrini F, Strippoli GF. Benefits and harms of statin therapy for persons with chronic kidney disease: a systematic review and meta-analysis. Ann Intern Med 2012;157:263-275.
    • (2012) Ann Intern Med , vol.157 , pp. 263-275
    • Palmer, S.C.1    Craig, J.C.2    Navaneethan, S.D.3    Tonelli, M.4    Pellegrini, F.5    Strippoli, G.F.6
  • 12
    • 84865658424 scopus 로고    scopus 로고
    • Lipid-lowering therapy in persons with chronic kidney disease: A systematic review and meta-analysis
    • Upadhyay A, Earley A, Lamont JL, Haynes S, Wanner C, Balk EM. Lipid-lowering therapy in persons with chronic kidney disease: a systematic review and meta-analysis. Ann Intern Med 2012;157:251-262.
    • (2012) Ann Intern Med , vol.157 , pp. 251-262
    • Upadhyay, A.1    Earley, A.2    Lamont, J.L.3    Haynes, S.4    Wanner, C.5    Balk, E.M.6
  • 15
    • 67650082354 scopus 로고    scopus 로고
    • Use of blood pressure lowering drugs in the prevention of cardiovascular disease: Meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies
    • Law MR, Morris JK, Wald NJ. Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies. BMJ 2009; 338:b1665.
    • (2009) BMJ , vol.338
    • Law, M.R.1    Morris, J.K.2    Wald, N.J.3
  • 16
    • 79959720383 scopus 로고    scopus 로고
    • Combined vascular effects of HMG-CoA reductase inhibitor and angiotensin receptor blocker in non-diabetic patients undergoing peritoneal dialysis
    • Han SH, Kang EW, Yoon SJ, Yoon HS, Lee HC, Yoo TH, Choi KH, Han DS, Kang SW. Combined vascular effects of HMG-CoA reductase inhibitor and angiotensin receptor blocker in non-diabetic patients undergoing peritoneal dialysis. Nephrol Dial Transplant 2011;26:3722-3728.
    • (2011) Nephrol Dial Transplant , vol.26 , pp. 3722-3728
    • Han, S.H.1    Kang, E.W.2    Yoon, S.J.3    Yoon, H.S.4    Lee, H.C.5    Yoo, T.H.6    Choi, K.H.7    Han, D.S.8    Kang, S.W.9
  • 18
    • 14544292416 scopus 로고    scopus 로고
    • Effects of atorvastatin on low-density lipoprotein cholesterol phenotype and C-reactive protein levels in patients undergoing long-term dialysis
    • Dornbrook-Lavender KA, Joy MS, Denu-Ciocca CJ, Chin H, Hogan SL, Pieper JA. Effects of atorvastatin on low-density lipoprotein cholesterol phenotype and C-reactive protein levels in patients undergoing long-term dialysis. Pharmacotherapy 2005;25:335-344.
    • (2005) Pharmacotherapy , vol.25 , pp. 335-344
    • Dornbrook-Lavender, K.A.1    Joy, M.S.2    Denu-Ciocca, C.J.3    Chin, H.4    Hogan, S.L.5    Pieper, J.A.6
  • 20
    • 33847248452 scopus 로고    scopus 로고
    • Simvastatin for secondary prevention of all-cause mortality and major coronary events in patients with mild chronic renal insufficiency
    • Chonchol M, Cook T, Kjekshus J, Pedersen TR, Lindenfeld J. Simvastatin for secondary prevention of all-cause mortality and major coronary events in patients with mild chronic renal insufficiency. Am J Kidney Dis 2007;49:373-382.
    • (2007) Am J Kidney Dis , vol.49 , pp. 373-382
    • Chonchol, M.1    Cook, T.2    Kjekshus, J.3    Pedersen, T.R.4    Lindenfeld, J.5
  • 22
    • 0037840242 scopus 로고    scopus 로고
    • MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: A randomised placebo-controlled trial
    • Collins R, Armitage J, Parish S, Sleigh P, Peto R. MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial. Lancet 2003;361:2005-2016.
    • (2003) Lancet , vol.361 , pp. 2005-2016
    • Collins, R.1    Armitage, J.2    Parish, S.3    Sleigh, P.4    Peto, R.5
  • 23
    • 71849095929 scopus 로고    scopus 로고
    • Effect of lovastatin on primary prevention of cardiovascular events in mild CKD and kidney function loss: A post hoc analysis of the Air Force/Texas Coronary Atherosclerosis Prevention Study
    • Kendrick J, Shlipak MG, Targher G, Cook T, Lindenfeld J, Chonchol M. Effect of lovastatin on primary prevention of cardiovascular events in mild CKD and kidney function loss: a post hoc analysis of the Air Force/Texas Coronary Atherosclerosis Prevention Study. Am J Kidney Dis 2010;55:42-49.
    • (2010) Am J Kidney Dis , vol.55 , pp. 42-49
    • Kendrick, J.1    Shlipak, M.G.2    Targher, G.3    Cook, T.4    Lindenfeld, J.5    Chonchol, M.6
  • 26
    • 77949332406 scopus 로고    scopus 로고
    • Efficacy of rosuvastatin among men and women with moderate chronic kidney disease and elevated highsensitivity C-reactive protein: A secondary analysis from the JUPITER (Justification for the Use of Statins in Prevention-an Intervention Trial Evaluating Rosuvastatin) trial
    • Ridker PM, MacFadyen J, Cressman M, Glynn RJ. Efficacy of rosuvastatin among men and women with moderate chronic kidney disease and elevated highsensitivity C-reactive protein: a secondary analysis from the JUPITER (Justification for the Use of Statins in Prevention-an Intervention Trial Evaluating Rosuvastatin) trial. J Am Coll Cardiol 2010;55:1266-1273.
    • (2010) J Am Coll Cardiol , vol.55 , pp. 1266-1273
    • Ridker, P.M.1    MacFadyen, J.2    Cressman, M.3    Glynn, R.J.4
  • 28
    • 0038512398 scopus 로고    scopus 로고
    • Effect of pravastatin on loss of renal function in people with moderate chronic renal insufficiency and cardiovascular disease
    • Tonelli M, Moye L, Sacks FM, Cole T, Curhan GC. Effect of pravastatin on loss of renal function in people with moderate chronic renal insufficiency and cardiovascular disease. J Am Soc Nephrol 2003;14:1605-1613.
    • (2003) J Am Soc Nephrol , vol.14 , pp. 1605-1613
    • Tonelli, M.1    Moye, L.2    Sacks, F.M.3    Cole, T.4    Curhan, G.C.5
  • 29
    • 1542287590 scopus 로고    scopus 로고
    • Does atorvastatin influence serum C-reactive protein levels in patients on long-term hemodialysis?
    • Vernaglione L, Cristofano C, Muscogiuri P, Chimienti S. Does atorvastatin influence serum C-reactive protein levels in patients on long-term hemodialysis? Am J Kidney Dis 2004;43:471-478.
    • (2004) Am J Kidney Dis , vol.43 , pp. 471-478
    • Vernaglione, L.1    Cristofano, C.2    Muscogiuri, P.3    Chimienti, S.4
  • 30
    • 77958484945 scopus 로고    scopus 로고
    • Effect of atorvastatin on kidney function in chronic kidney disease: A randomised double-blind placebo-controlled trial
    • Fassett RG, Robertson IK, Ball MJ, Geraghty DP, Coombes JS. Effect of atorvastatin on kidney function in chronic kidney disease: a randomised double-blind placebo-controlled trial. Atherosclerosis 2010;213:218-224.
    • (2010) Atherosclerosis , vol.213 , pp. 218-224
    • Fassett, R.G.1    Robertson, I.K.2    Ball, M.J.3    Geraghty, D.P.4    Coombes, J.S.5
  • 31
    • 0029811045 scopus 로고    scopus 로고
    • A prospective clinical trial comparing the treatment of idiopathic membranous nephropathy and nephrotic syndrome with simvastatin and diet, versus diet alone
    • Rayner BL, Byrne MJ, van Zyl Smit R. A prospective clinical trial comparing the treatment of idiopathic membranous nephropathy and nephrotic syndrome with simvastatin and diet, versus diet alone. Clin Nephrol 1996;46: 219-224.
    • (1996) Clin Nephrol , vol.46 , pp. 219-224
    • Rayner, B.L.1    Byrne, M.J.2    Van Zyl Smit, R.3
  • 32
    • 0036180635 scopus 로고    scopus 로고
    • Safety and efficacy of simvastatin in hypercholesterolemic patients undergoing chronic renal dialysis
    • Saltissi D, Morgan C, Rigby RJ, Westhuyzen J. Safety and efficacy of simvastatin in hypercholesterolemic patients undergoing chronic renal dialysis. Am J Kidney Dis 2002;39:283-290.
    • (2002) Am J Kidney Dis , vol.39 , pp. 283-290
    • Saltissi, D.1    Morgan, C.2    Rigby, R.J.3    Westhuyzen, J.4
  • 33
    • 0025990599 scopus 로고
    • Free oxygen species metabolism during haemodialysis with different membranes
    • Luciak M, Trznadel K. Free oxygen species metabolism during haemodialysis with different membranes. Nephrol Dial Transplant 1991;6(Suppl. 3):66-70.
    • (1991) Nephrol Dial Transplant , vol.6 , Issue.SUPPL. 3 , pp. 66-70
    • Luciak, M.1    Trznadel, K.2
  • 34
    • 27144534466 scopus 로고    scopus 로고
    • Effect of rosuvastatin on C-reactive protein and renal function in patients with chronic kidney disease
    • Verma A, Ranganna KM, Reddy RS, Verma M, Gordon NF. Effect of rosuvastatin on C-reactive protein and renal function in patients with chronic kidney disease. Am J Cardiol 2005;96:1290-1292.
    • (2005) Am J Cardiol , vol.96 , pp. 1290-1292
    • Verma, A.1    Ranganna, K.M.2    Reddy, R.S.3    Verma, M.4    Gordon, N.F.5
  • 37
    • 0037166636 scopus 로고    scopus 로고
    • Association of kidney function with anemia: The Third National Health and Nutrition Examination Survey 1988-1994)
    • Astor BC, Muntner P, Levin A, Eustace JA, Coresh J. Association of kidney function with anemia: the Third National Health and Nutrition Examination Survey (1988-1994). Arch Intern Med 2002;162:1401-1408.
    • (2002) Arch Intern Med , vol.162 , pp. 1401-1408
    • Astor, B.C.1    Muntner, P.2    Levin, A.3    Eustace, J.A.4    Coresh, J.5
  • 38
    • 0042885985 scopus 로고    scopus 로고
    • Arterial media calcification in end-stage renal disease: Impact on all-cause and cardiovascular mortality
    • London GM, Guerin AP, Marchais SJ, Metivier F, Pannier B, Adda H. Arterial media calcification in end-stage renal disease: impact on all-cause and cardiovascular mortality. Nephrol Dial Transplant 2003;18:1731-1740.
    • (2003) Nephrol Dial Transplant , vol.18 , pp. 1731-1740
    • London, G.M.1    Guerin, A.P.2    Marchais, S.J.3    Metivier, F.4    Pannier, B.5    Adda, H.6
  • 39
    • 3042844018 scopus 로고    scopus 로고
    • Association between serum homocysteine and markers of impaired kidney function in adults in the United States
    • Francis ME, Eggers PW, Hostetter TH, Briggs JP. Association between serum homocysteine and markers of impaired kidney function in adults in the United States. Kidney Int 2004;66:303-312.
    • (2004) Kidney Int , vol.66 , pp. 303-312
    • Francis, M.E.1    Eggers, P.W.2    Hostetter, T.H.3    Briggs, J.P.4
  • 40
    • 26244432388 scopus 로고    scopus 로고
    • Efficacy and safety of cholesterol-lowering treatment: Prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins
    • Baigent C, Keech A, Kearney PM, Blackwell L, Buck G, Pollicino C, Kirby A, Sourjina T, Peto R, Collins R, Simes R. Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins. Lancet 2005;366:1267-1278.
    • (2005) Lancet , vol.366 , pp. 1267-1278
    • Baigent, C.1    Keech, A.2    Kearney, P.M.3    Blackwell, L.4    Buck, G.5    Pollicino, C.6    Kirby, A.7    Sourjina, T.8    Peto, R.9    Collins, R.10    Simes, R.11
  • 41
    • 0016403709 scopus 로고
    • Accelerated atherosclerosis in prolonged maintenance hemodialysis
    • Lindner A, Charra B, Sherrard DJ, Scribner BH. Accelerated atherosclerosis in prolonged maintenance hemodialysis. N Engl J Med 1974;290:697-701.
    • (1974) N Engl J Med , vol.290 , pp. 697-701
    • Lindner, A.1    Charra, B.2    Sherrard, D.J.3    Scribner, B.H.4
  • 43
    • 48049086334 scopus 로고    scopus 로고
    • Sudden cardiac death and dialysis patients
    • Herzog CA, Mangrum JM, Passman R. Sudden cardiac death and dialysis patients. Semin Dial 2008;21:300-307.
    • (2008) Semin Dial , vol.21 , pp. 300-307
    • Herzog, C.A.1    Mangrum, J.M.2    Passman, R.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.